Status:
COMPLETED
Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation)
Lead Sponsor:
University of Utah
Conditions:
Platelet Function
Thrombocytopenia
Eligibility:
All Genders
Brief Summary
Platelet transfusions are routinely administered during neonatal ECMO, with an average of 1.3 platelet transfusions per day being administered while a patient is undergoing ECMO treatment. The cause o...
Detailed Description
Platelet transfusions are routinely administered during neonatal ECMO, with an average of 1.3 platelet transfusions per day being administered while a patient is undergoing ECMO treatment.1 In general...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Any patient on ECMO will be eligible for study.
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00748878
Start Date
June 1 2008
End Date
June 1 2013
Last Update
October 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Children's Medical Center
Salt Lake City, Utah, United States, 84113